GlassScriptPhysician profile
Patrick M Riley
NPI 1396304507
$2,402.58
in general payments reported to CMS, 2019-2025
17 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $692 · 2023: $1,065 · 2024: $131 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.97 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $554.23 | 2021-2024 | Breztri, Fasenra, Tezspire |
| Amgen INC. | $408.91 | 2022-2025 | Tezspire |
| Glaxosmithkline, LLC. | $245.48 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.08 | 2022-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Fisher & Paykel Healthcare INC | $174.54 | 2022-2025 | Fisher & Paykel Healthcare |
| Jazz Pharmaceuticals INC. | $162.20 | 2022-2025 | |
| Genzyme Corporation | $144.34 | 2023-2025 | |
| Grifols USA, LLC | $116.59 | 2022-2023 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $108.08 | 2023 | Dupixent |
| Pfizer INC. | $79.53 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.10 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $33.51 | 2022 | |
| Baxter Healthcare | $30.90 | 2023 | Hillrom - Life 2000 Ventilation System |
| 3b Medical, INC. | $28.09 | 2025 | Luna |
| Alexion Pharmaceuticals, INC. | $25.91 | 2025 | Ultomiris |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.85 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.